Abeona Therapeutics Inc
LSE:0H7R
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abeona Therapeutics Inc
LSE:0H7R
|
US |
|
T
|
Terna Rete Elettrica Nazionale SpA
DUS:UEI
|
IT |
|
P
|
Paychex Inc
XBER:PCX
|
US |
|
A
|
Activision Blizzard Inc
XETRA:AIY
|
US |
|
S
|
Shin-Etsu Chemical Co Ltd
SWB:SEH
|
JP |
|
Intellia Therapeutics Inc
LSE:0JBU
|
US |
|
P
|
Philip Morris International Inc
DUS:4I1
|
US |
|
Regional Management Corp
NYSE:RM
|
US |
Wall St Price Targets
0H7R Price Targets Summary
Abeona Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 0H7R is 20.04 USD with a low forecast of 12.9 USD and a high forecast of 28.88 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0H7R's stock price target?
Price Target
20.04
USD
According to Wall Street analysts, the average 1-year price target for 0H7R is 20.04 USD with a low forecast of 12.9 USD and a high forecast of 28.88 USD.
What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
71%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 71%.
What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
16%
The compound annual growth rate for Net Income over the next 8 years is 16%.
